search
ARKG
Trends
- 1Cathie Wood's ARKG Biotech Bets Surge Nearly Sixfold This Year●Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year
Two biotech holdings in Cathie Wood's ARK Genomic Revolution ETF (ARKG) have surged nearly six times in value this year, making the genomics fund the strongest performer among ARK Invest's lineup of ETFs. The outsized gains from the two biotech positions are driving the fund's advantage over her other products, drawing attention to Wood's high-conviction bets in genomics.